XX% We morning, and of quarter the third million, the call. revenue ended thank our prior Thanks, earnings an period. Kelly. of you increase $XX.X over year quarter with joining XXXX third for Good
of financial our expectations. results fell short However,
XXXX and earnings growth by quarter's a second XX-plus internationally call, handhelds, to including of last we half number domestically. driven our expected opportunities in noted we As be placement unit
sizable many passing were devices secured than in due during contracts. a the from delays handheld with delay federal we and and placements resulting part expected budget quarter, to the period in the orders compressed XXX less placed spending advancing total While international in third
we our instrumentation in see desktop addition, elongating In continue softness bioprocessing the life to cycle sales and of devices. science the market,
guidance materialized. Our a yet quicker in sharper half prior contemplated and recovery second demand, which XXXX hasn't
XXXX our X marked XX% moments. delayed the appropriately the of our $XX Given are of muted the $XX will spending in provide months
The to year, growth. detail few on be million million, in range Technology. the RedWave the we representing closing and lowering environment end revenue our ending Joe opportunity to with government guidance fiscal XXXX U.S. to acquisition since guidance more of the XX% a of October of
be rationale the about remains excited and our We the unchanged. union of continue to incredibly together companies for platforms bringing absolutely two two the
for markets harmonized and creates platform we evident serve entire even the last customers Reflecting offering over months, with dynamics on As equipped X become path for portfolio, further gross across a we cost in more that operationally, are a the serve better expanded combined by our now shifting decision our to combined it's the margins support. back products. our our of learnings efficiency our all company,
growth beyond. implementing time to and are adjustment changes into the and as the for we is these of the transformation believe right now prepare XXXX structural lean We three accelerate XXX
[indiscernible] moved manufacturing Connecticut, our devices. We year, phase. this production We rate product AVCAD on which manufacturing partnership desktop take in are full site locations. out by the will to Detection potential of the our production and successfully we production to of our in XXXX QX end move now Morrisville, of North earlier Carolina will Boston of Smiths our consumable with in lower-cost of expansion and First, this facilities Carolina chips Danbury, completed North the
compared expected the week, in reduction our reduce action for industry which Danbury offers sales, to and agility to device current This instrumentation positions Boston, marketing over team's reduction we to Our facility approximately costs $X.X market representing growth. million XXXX roughly and leveraged enhances our $X.X approximately starting our of gross annual time volume annually efforts recovers. included to by life on opportunities and this million XX%, rent is our Last site as will the be to a workforce save expand XX% R&D. highest importantly, margins in in for handheld, savings took capitalize science products, and
efficiency, our take Third, for new quickly growth optimizing flexibility advantage focus opportunities. full sales to organization and of we're
For and year-to-date. represented a about RedWave demos virtual of our driving page from combined XX% RedWave program, efficiently established and inside of handhelds, sales the leverage sales includes playbook taking through Buy sales Try Before device You which efforts with this their
from forensics gain our our leaning This a the has biopharma for into are effective strategy going we partnerships to will desktops, therapy channel subscale expand in Europe international and proven our space with the bioprocessing direct pursue we reach, space. back through further step in particularly team. model specialized account partners innovators, To equipment For forward. gene our our larger sales presence across cell team to
is environment XXX's penetrate and to our strength of to elements and long assessment, resourced commercial near, in our operate government handheld. With a achieve accelerate growth medium engine the this. term. in adoption cap across ability enterprise enterprise believe accounts. and to radiate remain key in an five ability and increasing confident growth A One, FTR the our of lower of growth well we've identified remain create With these we to we adjustments, acceleration to
including Prisons the Just Bureau EU global program National Vietnam months, the multiple over U.S. into adopted last MXXXX Guard Counter Drug few Drug Guard, Border Detect the for was and enterprise the Program. accounts,
Agency Environmental Navy we FTR QX. U.S. and products, the U.S. U.S. our Protection the For Guard, in purchases with secured initial Coast
in development. of prospecting, again device, cycle These handheld. following making a untapped all handheld. initial for release FTR X device RedWave's with the customers, of of the disrupt X,XXX opportunities next We're our major to large upgrade pull-through product our XXXX. Explorer We're next-generation to identified MXXXX's see We a of pipeline including Smiths a step that as a into potential full take the great XXXX. previously the
Number the placements opportunity. enterprise months performance been Three, new goods change are of partnership creating a award of half develop, pleased but enterprise program release with higher late with size to and within production newest sometimes rate will X years in yet and for offering devices in cost Now and the AVCAD to U.S. anticipate the have be see with generation we've Over time, winning year-to-date units and opportunity. inroads the Department which an double Detection. Explorer of years, contributor simplicity hundreds Defense already products, large strong weight, its a MXXXX deployed represents our preparing government since with next those already two, of MXXXX trajectory market lower it's
analytical for potential. have delivered MXXXX contract, services, thousands developing of rate which are outlook gene for date, the and of units therapy the The the initial R&D under We novel or represents and biopharma fundamental To give complementary instruments. process will we adoption and PAT low remains us U.S. program-wide the growth. of we devices, variant MAVEN process industry a tools across the year, need spending production, MAVERICK. novel armed both annually. over emphasis units Last is which approximately spending together frontline technology biopharma full return the is with a CapEx million cell within key for $XX and on result return milestone point for anticipated Market fiscal decision phase next XXX rate to and workers. that on game-changing government's year.Â
Number anticipated analytical regulators in X The launched confidence XXXX four, Smith. The is is production reports of to
trials have customer had engagement, evaluations. we seen good prolonged product and we've While
manufacturing, unit to we the suit. PD of includes MAVEN and On our MAVERICK XX-plus expect for pipeline multiple across follow positive, and engagements opportunities GMP now
We are integrations reaching over for XX as months.Â
Five, next headwinds expect in more the significantly QX pipeline convert desktops expecting scale. and partner to sequential improvements funding this lessen
path We scale through to devices the process market of integration innovators equipment. an efficient and is for partnerships continue our desktop with believe to
our We are working to scale with enable these multiple placements with to partners. secure to companies design wins
We Solaris others with have than projects well and and are previously with announced Terumo and progressing more BTT, a therapy. across cell biologics of we X pipeline
relentless work our pursuit desktop year. into now of of of growth the focus result which are view we our anticipated orders and of X about environment, QX QX, of this and entire portfolio norm team.Â
While our only formally I device. areas: coming back, of a operational MXXXX result team the are hard elements of see our in a recovery these half been excellence. For and our started dedication this of improvement. a Many our as For handheld has seasonality that, our we flagship expecting XXXX Stepping second aren't engagement since half demand portfolio the encouraging we launch for V-shaped signs the strong market expansion, thank in effort,
the multiunit growth CAGR X and has evidenced be done Our at over these our results times, and organic positive been line the on years, clear growth government certainly to QX revenue government fantastic XXXX. has opportunities into continues job trend between and and remains but QX, team a sales past large executing delivering a expectations XX% Handheld lumpy XXXX is clear. by
and color growth our our margin New I'll for a the cost Joe us, to XXXX additional operations for turn that, fixed to to With and related we subsequent more now transformative opportunities our over opportunities calls. manufacturing in alongside detail call expansion to growth in plan provide be financials. and for on up trajectory paired margin year sets
